ultrasound contrast agents

26
Ultrasound Contrast Agents By: naseem abu hawash

Upload: naseem-abu-hawash

Post on 26-Jan-2017

43 views

Category:

Health & Medicine


0 download

TRANSCRIPT

Page 1: Ultrasound contrast agents

Ultrasound Contrast Agents

By: naseem abu hawash

Page 2: Ultrasound contrast agents

Ultrasound contrast agents rely on the different ways in which sound waves are reflected from interfaces between substances.

This may be the surface of a small air bubble or a more complex structure .

Commercially available contrast media are gas-filled microbubbles that are administered intravenously to the systemic circulation

Page 3: Ultrasound contrast agents

Microbubbles have a high degree of echogenicity (the ability of an object to reflect ultrasound waves). There is a great difference in echogenicity between the gas in the microbubbles and the

soft tissue surroundings of the body . Contrast-enhanced ultrasound can be used to image blood perfusion in organs,

measure blood flow rate in the heart and other organs, and for other applications

Page 4: Ultrasound contrast agents

These micron-sized particles consist of a gas core surrounded by a lipid shell, and are injected

intravenously into the circulatory system .Understanding the patterns of blood flow is a powerful tool for evaluating the differences between normal and pathological tissues.•

Page 5: Ultrasound contrast agents

•Size of Microbubble is around 1 - 4 μm

•The Microbubble is nearly around the size of RBCs as it should not cross the vascular endothelium .

Page 6: Ultrasound contrast agents

types

Page 7: Ultrasound contrast agents

Types

1.Non-targeted contrast-enhanced ultrasound 2.Targeted contrast- enhanced ultrasound

1.Non-targeted contrast-enhanced ultrasound

More common method

In this the microbubbles will remain in the systemic circulation for a certain period of time. During that time, ultrasound waves are directed on the area of interest. When microbubbles in the blood flow past the imaging window, the microbubbles’ compressible reflect a unique echo.

Page 8: Ultrasound contrast agents

Uses of Non-targeted contrast-enhanced ultrasound

To enhance the contrast at the interface between the tissue and blood.

A clearer picture of the structure of an organ

Evaluating the degree of blood perfusion and evaluating the blood volume in an organ or area of interest .

Differentiation between benign and malignant focal liver lesions

Page 9: Ultrasound contrast agents

Liver absces

Page 10: Ultrasound contrast agents
Page 11: Ultrasound contrast agents

Targeted contrast-enhanced ultrasound

Contrast agents designed to bind to specific molecules, which are then targeted at tissues expressing that substance.

Microbubbles targeted with ligands that bind certain molecular markers that are expressed by the area of imaging.

Microbubbles theoretically travel through the circulatory system, eventually finding their respective targets and binding

specifically .

Page 12: Ultrasound contrast agents

Targeting ligands that bind to receptors characteristic of intravascular diseases can be conjugated to microbubbles ,

enabling the microbubble complex to accumulate selectively in areas of interest, such as diseased or abnormal tissues.

This form of molecular imaging, known as targeted contrast-enhanced ultrasound, will only generate a strong ultrasound

signal if targeted microbubbles bind in the area of interest .

Targeted contrast-enhanced ultrasound may have many applications in both medical diagnostics and medical

therapeutics .

Page 13: Ultrasound contrast agents
Page 14: Ultrasound contrast agents
Page 15: Ultrasound contrast agents
Page 16: Ultrasound contrast agents

uses

Inflammation: Contrast agents may be designed to bind to certain proteins that become expressed in inflammatory diseases such as Crohn's disease, atherosclerosis, and even heart attacks

Thrombosis (is the formation of a blood clot inside a blood vessel) and thrombolysis: Contrast Agents specifically bind to activated platelets and allow real-time molecular imaging of thrombosis, such as in myocardial infarction, as well as monitoring success or failure of pharmacological thrombolysis.

Page 17: Ultrasound contrast agents

Focal liver lesion

Page 18: Ultrasound contrast agents

Prostate cancer

Page 19: Ultrasound contrast agents

contrast imaging techniques

There are two contrast imaging techniques, linear and nonlinear.

Page 20: Ultrasound contrast agents

Linear contrast agent imaging refers to visualizing the microbubble contrast agents using B-Mode imaging and then applying a reference subtraction algorithm to apply a green contrast overlay on the image to aid in the visualization and

quantification of the contrast specific signal .

This type of imaging is available both on the Vevo 770 as well as on the Vevo 2100 system.

Page 21: Ultrasound contrast agents
Page 22: Ultrasound contrast agents
Page 23: Ultrasound contrast agents

Nonlinear contrast agent imaging uses multiple ultrasound pulses in which the amplitude of the pulse is modulated, by performing this type of imaging the nonlinear response of the microbubbles to ultrasound pulses is utilized. The goal of this type of imaging is to suppress the tissue signal while increasing the detection of the contrast agents, providing a much more sensitive imaging technique. Nonlinear contrast imaging is only possible on the Vevo 2100 system using the MS200 and MS250 transducers.

Page 24: Ultrasound contrast agents
Page 25: Ultrasound contrast agents

Disadvantages of CEUSMicrobubbles don’t last very long in circulation .

They have low circulation residence times because they either get taken up by immune system cells or get taken up by the liver or spleen even when they are coated with PEG.

Ultrasound produces more heat as the frequency increases. Monitering Required

Page 26: Ultrasound contrast agents

Targeting ligands can be immunogenic, since current targeting ligands used in preclinical experiments are derived from animal culture.

Low targeted microbubble adhesion efficiency. This is main reasons that targeted contrast-enhanced ultrasound remains in the preclinical development stages